218 related articles for article (PubMed ID: 12731662)
1. Multistep tumorigenesis of multiple myeloma: its molecular delineation.
Iida S; Ueda R
Int J Hematol; 2003 Apr; 77(3):207-12. PubMed ID: 12731662
[TBL] [Abstract][Full Text] [Related]
2. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.
Avet-Loiseau H; Facon T; Daviet A; Godon C; Rapp MJ; Harousseau JL; Grosbois B; Bataille R
Cancer Res; 1999 Sep; 59(18):4546-50. PubMed ID: 10493504
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing primary and secondary translocations in multiple myeloma.
Gabrea A; Leif Bergsagel P; Michael Kuehl W
DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
[TBL] [Abstract][Full Text] [Related]
4. Functional significance of genetic abnormalities in multiple myeloma.
Gadó K; Domján G; Kormos L; Falus A
Haematologia (Budap); 2002; 32(3):191-208. PubMed ID: 12611480
[TBL] [Abstract][Full Text] [Related]
5. Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma.
Chim CS; Liang R; Leung MH; Kwong YL
J Clin Pathol; 2007 Jan; 60(1):104-6. PubMed ID: 17213358
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of myeloma.
Anderson KC; Carrasco RD
Annu Rev Pathol; 2011; 6():249-74. PubMed ID: 21261519
[TBL] [Abstract][Full Text] [Related]
7. 4q loss is potentially an important genetic event in MM tumorigenesis: identification of a tumor suppressor gene regulated by promoter methylation at 4q13.3, platelet factor 4.
Cheng SH; Ng MH; Lau KM; Liu HS; Chan JC; Hui AB; Lo KW; Jiang H; Hou J; Chu RW; Wong WS; Chan NP; Ng HK
Blood; 2007 Mar; 109(5):2089-99. PubMed ID: 17077331
[TBL] [Abstract][Full Text] [Related]
8. Molecular aspects of multiple myeloma.
Kastrinakis NG; Gorgoulis VG; Foukas PG; Dimopoulos MA; Kittas C
Ann Oncol; 2000 Oct; 11(10):1217-28. PubMed ID: 11106109
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of immunoglobulin light chain gene aberrations as revealed by FISH in multiple myeloma and MGUS.
Türkmen S; Binder A; Gerlach A; Niehage S; Theodora Melissari M; Inandiklioglu N; Dörken B; Burmeister T
Genes Chromosomes Cancer; 2014 Aug; 53(8):650-6. PubMed ID: 24729354
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
Zojer N; Schuster-Kolbe J; Assmann I; Ackermann J; Strasser K; Hübl W; Drach J; Ludwig H
Br J Haematol; 2002 Jun; 117(4):852-9. PubMed ID: 12060120
[TBL] [Abstract][Full Text] [Related]
12. Chromosome translocations in multiple myeloma.
Bergsagel PL; Kuehl WM
Oncogene; 2001 Sep; 20(40):5611-22. PubMed ID: 11607813
[TBL] [Abstract][Full Text] [Related]
13. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J
Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal and genetic abnormalities in myeloma.
Joy Ho P
Clin Lab Haematol; 2002 Oct; 24(5):259-69. PubMed ID: 12358886
[TBL] [Abstract][Full Text] [Related]
15. Aberrant p15, p16, p53, and DAPK Gene Methylation in Myelomagenesis: Clinical and Prognostic Implications.
Geraldes C; Gonçalves AC; Cortesão E; Pereira MI; Roque A; Paiva A; Ribeiro L; Nascimento-Costa JM; Sarmento-Ribeiro AB
Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):713-720.e2. PubMed ID: 27622827
[TBL] [Abstract][Full Text] [Related]
16. The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.
Mikulasova A; Wardell CP; Murison A; Boyle EM; Jackson GH; Smetana J; Kufova Z; Pour L; Sandecka V; Almasi M; Vsianska P; Gregora E; Kuglik P; Hajek R; Davies FE; Morgan GJ; Walker BA
Haematologica; 2017 Sep; 102(9):1617-1625. PubMed ID: 28550183
[TBL] [Abstract][Full Text] [Related]
17. Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis.
Davies FE; Dring AM; Li C; Rawstron AC; Shammas MA; O'Connor SM; Fenton JA; Hideshima T; Chauhan D; Tai IT; Robinson E; Auclair D; Rees K; Gonzalez D; Ashcroft AJ; Dasgupta R; Mitsiades C; Mitsiades N; Chen LB; Wong WH; Munshi NC; Morgan GJ; Anderson KC
Blood; 2003 Dec; 102(13):4504-11. PubMed ID: 12947006
[TBL] [Abstract][Full Text] [Related]
18. [Molecular Mechanism and Malignant Clonal Evolution of Multiple Myeloma].
Ding F; Zhu P; Wu XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1513-6. PubMed ID: 26524068
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of genetic aberrations in human multiple myeloma cell lines and newly diagnosed MM by fluorescence in situ hybridization].
An G; Xie ZQ; Li CH; Li Q; Yi SH; Qiu LG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1505-10. PubMed ID: 21176360
[TBL] [Abstract][Full Text] [Related]
20. New insights into role of microenvironment in multiple myeloma.
Tricot GJ
Int J Hematol; 2002 Aug; 76 Suppl 1():334-6. PubMed ID: 12430876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
